MedPath

Genetic Variants Affecting the Clinical Severity of Beta Thalassemia

Conditions
Beta Thalassemia
Interventions
Diagnostic Test: Hematological Analysis and Genetical Analysis
Registration Number
NCT04918056
Lead Sponsor
Nanfang Hospital, Southern Medical University
Brief Summary

β-thalassemia is one of the most common single gene disorder in Southern China. The phenotypic severity of beta thalassemia widely varies from mild to severe forms. Patients with the same beta thalassemia genotype show wide phenotypic variability that ranges from moderate to severe disease due to various genetic modifiers of disease severity. The aim of this study is to looking for the genetic factors which could affect the severity of beta thalassemia.

Detailed Description

The understanding of the genotype-phenotype correlation is a very important issue to the precise diagnosis of beta thalassemia. However, the genotype-phenotype correlation of Beta thalassemia is so complex that the pathogenesis of some patients remains uncertain and cannot be explained by known mechanisms. The study of the role of the genetic variants in modulating beta thalassemia phenotype could brought us considerable novel and interesting information in this area. We will collecting more than 1000 beta thalassemia patients , analyzing their clinical data and genome data, and association study will be conducted to screen the positive genetic variants which exert a significant effect on both the HbF levels and onset ages of beta thalassemia patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1300
Inclusion Criteria
  • Diagnosed with β-thalassemia
Exclusion Criteria
  • Iron Deficiency Anemia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
beta thalassemia patientsHematological Analysis and Genetical Analysis-
Primary Outcome Measures
NameTimeMethod
Genetic variants which could influence the phenotype of beta thalassemia1 year

Identified a group of single-nucleotide polymorphisms (SNPs) that contribute to β-thalassemia

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath